This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

SAN-AL-61

DiaMedica Inc.

Drug Names(s): SAN-61

Description: SAN-AL-61 is a naturally occurring amyloid cleaving enzyme. It has also been suggested that SAN-AL-61 prevents glycogen synthetase kinase 3 - beta (GSK-3ß) activation, which in turn could prevent Tau hyperphosphorylation.

Deal Structure: DiaMedica and Sanomune
In December 2009, DiaMedica announced it has entered into a non-binding letter of intent to acquire all of the issued and outstanding shares of Sanomune Inc. In June 2010, the acquisition was completed.


SAN-AL-61 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug